Effectiveness of Collaborative care and Duloxetine for major depressive disorder and (sub)chronic pain in primary care: a randomized placebo-controlled Multi-Centre trial.
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2014
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder; Pain
- Focus Therapeutic Use
- Acronyms PAINDIP
- Sponsors Eli Lilly
- 03 Feb 2014 Planned number of patients changed from 237 to 219 as reported by European Clinical Trials Database record.
- 07 Jun 2011 New trial record